|
Tender Result Brief :
|
Contract awarded for Varicella vaccine and combined mmr vaccine
{
"detected_language": "hungarian",
"translated_text": "lot-0001, title: varicella vaccine, description: the contracting authority is procuring varicella vaccine for children under 2 years of age according to a 2-dose scheme under a purchase agreement. vaccine name: varicella vaccine for children under 2 years of age, 2-dose scheme atc code: j07bk01 total quantity: 360,000 doses + 36,000 doses option; the seller may deviate by 2% from the quantity specified for each storage deadline, considering the manufacturing batches of the vaccine, with the condition that the total quantity must be stored by the expiration of the purchase agreement. in case of a quantity deviation not reaching 2%, the consequences specified in this purchase agreement shall not apply. packaging: 1 x 1 dose syringe, if the offered product is in ampoule packaging, 2 needles and 1 syringe of the type recommended by who must be attached to the vaccine. if the seller can deliver a different quantity per dose than the offered packaging, but lower than 20 doses, the seller is obliged to inform the buyer in writing before delivery, and the buyer is entitled to accept a different packaging than the one offered. if the seller can deliver a different quantity per dose than the offered packaging, but equal to or higher than 20 doses, the seller must request the buyer's prior written permission before delivery, and the buyer is entitled to accept a different packaging than the one offered. quality requirement: the vaccine must comply with who trs 848: requirements for varicella vaccine (live); and the requirements of the european pharmacopoeia 01/2019:0648 monograph. usability: the vaccine must be usable for at least 16 months from the date of delivery. at the request of the seller, the buyer is entitled to authorize the delivery of vaccine with a shorter usability period in a separate written statement, provided that the seller guarantees unconditional and immediate replacement for the unused quantity. the usability period of the replaced vaccine shall be determined in writing by the parties in each case. storage deadlines: september 1, 2026: 15,000 doses december 10, 2026: 40,000 doses february 1, 2027: 80,000 doses august 1, 2027: 75,000 doses february 1, 2028: 45,000 doses may 2, 2028: 35,000 doses august 1, 2028: 35,000 doses december 1, 2028: 35,000 doses marketing authorization: the vaccine must have a valid marketing authorization issued by the pharmaceutical authority (nngyk, or previously ogyéi /gyemszi/ ogyi) or by the eu under regulation (ec) no 726/2004, regulation (ec) no 1901/2006 or regulation (ec) no 1394/2007 at the time of the offer submission. wholesale drug license: the bidder must have a valid wholesale drug license covering the product group subject to the public procurement according to the 53/2004 (vi.2.) eszcsm regulation and the 2005. year xcv law at the time of the offer submission. packaging: the offered vaccine must comply with the detailed rules regarding safety features to be placed on the outer packaging of medicinal products for human use as specified in the amendment to directive 2001/83/ec by commission delegated regulation (eu) 2016/161 of october 2, 2015. the contracting authority accepts foreign language packaging, but a hungarian language patient information leaflet is required. during delivery, the total quantity of the vaccine due at the specified storage date must be delivered to the place of performance, and during storage, the total quantity of the vaccine due at the specified storage date must be made available to the contracting authority in a marketable manner. lot-0002, title: combined mmr vaccine, description: the contracting authority is procuring a combined measles, mumps, rubella vaccine for vaccinations due at 15 months and 11 years of age under a purchase agreement. atc code: j07bd52 total quantity: 465,000 doses + 46,500 doses option packaging: 1 x 1 dose, or 10 x 1 dose, if the offered product is in ampoule packaging, 2 needles and 1 syringe of the type recommended by who must be attached to the vaccine. if the seller can deliver a different quantity per dose than the offered packaging, but lower than 20 doses, the seller is obliged to inform the buyer in writing before delivery, and the buyer is entitled to accept a different packaging than the one offered. if the seller can deliver a different quantity per dose than the offered packaging, but equal to or higher than 20 doses, the seller must request the buyer's prior written permission before delivery, and the buyer is entitled to accept a different packaging than the one offered. quality requirement: the vaccine must comply with who trs 840: requirements for measles mumps and rubella vaccines and combined vaccine (live) adopted 1992., (requirements for biological substances no. 47.); and the requirements of the european pharmacopoeia 04/2022:1057 monograph. usability: the vaccine must be usable for at least 18 months from the date of delivery. at the request of the seller, the buyer is entitled to authorize the delivery of vaccine with a shorter usability period in a separate written statement, provided that the seller guarantees unconditional and immediate replacement for the unused quantity. the usability period of the replaced vaccine shall be determined in writing by the parties in each case. storage deadlines:
estimated value excluding vat: 2439855000.00 huf.Varicella vaccine and combined mmr vaccine
|
